EDGAR Filing Documents for 0001213900-23-048616

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001213900-23-048616

Filing Date

2023-06-13

Accepted

2023-06-13 17:00:47

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	REGISTRATION STATEMENT	ea180051-s3_hoththerape.htm	S-3	341628
2	FORM OF SENIOR INDENTURE	ea180051ex4-3_hoththerape.htm	EX-4.3	296465
3	FORM OF SUBORDINATED INDENTURE	ea180051ex4-4_hoththerape.htm	EX-4.4	276661
4	OPINION OF SHEPPARD MULLIN RICHTER & HAMPTON LLP	ea180051ex5-1_hoththerape.htm	EX-5.1	31302
5	CONSENT OF WITHUMSMITH+BROWN, PC	ea180051ex23-1_hoththerape.htm	EX-23.1	2766
6	FILING FEE TABLE	ea180051ex-fee_hoththerape.htm	EX-FILING FEES	12693
7	GRAPHIC	image_001.jpg	GRAPHIC	3425
8	GRAPHIC	ex5-1_001.jpg	GRAPHIC	2690
	Complete submission text file	0001213900-23-048616.txt		971177

Mailing Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020

Business Address 1 ROCKEFELLER PLAZA, SUITE 1039 NEW YORK NY 10020 551-578-2261

Hoth Therapeutics, Inc. (Filer) CIK: 0001711786 (see all company filings)